Tag: access

RENO, Nev., July 07, 2025 (GLOBE NEWSWIRE) -- Ormat Technologies Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company, today announced that it plans to publish its second quarter financial results in a press release that will be issued on Wednesday, August 6, 2025, after the market closes. In conjunction with this report, the Company has scheduled a conference call to discuss the results at 10:00 a.m. ET on Thursday, August 7, 2025.

Highland, Indiana, July 07, 2025 (GLOBE NEWSWIRE) -- REsimpli, a leading all-in-one AI CRM for Real Estate Investors, is thrilled to announce the launch of its REsimpli 5.0 release that introduces 8 powerful AI Agent tools and a List Pulling Feature that help investors pull off-market properties with necessary filters for the best results. These tools are designed to automate communication, reduce response times, and dramatically improve conversion rates.

Press release
Brussels, 7 July 2025

LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- MURANO GLOBAL INVESTMENTS PLC (NASDAQ: MRNO) (“Murano” or the “Company”) today announced an enhancement to its corporate strategy aimed at building a Bitcoin (BTC) Treasury. The Company will continue with its core strategy of developing real estate and operating its Mexican hotel and resort business while simultaneously leveraging its operating cash flows, substantial real estate holdings, and access to capital markets to build a robust Bitcoin Treasury.

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company’s proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a purpose-built Layer 1 blockchain for artificial intelligence infrastructure, has initiated its Bonus Round token offering after completing 15 successful presale stages and raising a total of $20.9 million.